Vor Biopharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Vor Biopharma generated cash of -$100,292,000, which is less than the previous year. Cash used in financing activities reached the amount of $2,938,000 last year. Net change in cash is therefore -$26,346,000.
Cash Flow
| 2018 | -2.66M | 0 | 2.46M |
|---|---|---|---|
| 2019 | -9.85M | -748K | 17.69M |
| 2020 | -36.29M | -4.16M | 82.52M |
| 2021 | -69.14M | -91.65M | 232.91M |
| 2022 | -85.14M | -94.09M | 117.14M |
| 2023 | -100.29M | 71.00M | 2.93M |
VOR Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 60.11M | 122.21M | 50.09M | 8.02M | 929K | 1.12M |
Operating activities | ||||||
Net income | -117.86M | -92.09M | -68.89M | -43.33M | -10.83M | -4.15M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 3.49M | 2.52M | 1.43M | 605K | 91K | 20K |
Stock-based compensation expense | 13.36M | 10.69M | 4.31M | 1.34M | 172K | 0 |
| Deferred income tax benefit | 13.36M | 10.69M | 4.31M | 1.34M | 172K | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 2.85M | 0 | 405K | 5.82M | 1.21M | 0 |
Cash generated by operating activities | -100.29M | -85.14M | -69.14M | -36.29M | -9.85M | -2.66M |
Investing activities | ||||||
Purchases Of Investments | -74.92M | -123.18M | -87.75M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.06M | -8.46M | -3.89M | -4.16M | -748K | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 71.00M | -94.09M | -91.65M | -4.16M | -748K | 0 |
Financing activities | ||||||
Common Stock Issued | 4.57M | 115.97M | 232.91M | 82.26M | 17.69M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -1.18M | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 2.93M | 117.14M | 232.91M | 82.52M | 17.69M | 2.46M |
Net Change In Cash | -26.34M | -62.09M | 72.11M | 42.07M | 7.09M | -197K |
Cash at end of period | 33.77M | 60.11M | 122.21M | 50.09M | 8.02M | 929K |
| Data source | Data source | Data source | Data source |